Is AJCC/UICC Staging Still Appropriate for Head and Neck Cancers in Developing Countries?

By 2030, 70% of cancers will occur in developing countries. Head and neck cancers are primarily a developing world disease. While anatomical location and the extent of cancers are central to defining prognosis and staging, the American Joint Committee on Cancer (AJCC)/International Union Against Can...

Full description

Bibliographic Details
Main Authors: Johannes J. Fagan MBChB, MMed, FCS, Julie Wetter MBChB, MMed, FCRadOnc, Jeffrey Otiti MBCHB, MMed, Joyce Aswani MBChB, MMed, Anna Konney MD, FWACS, FGCPS, Evelyne Diom, Kenneth Baidoo MD, FWACS, FGCS, Paul Onakoya MBBS, Rajab Mugabo MMed, Patrick Noah MBBS, FCS, Victor Mashamba MD, MMed, Innocent Kundiona MBChB, MMed, Chege Macharia MBChB, FCS, Mohammed Garba Mainasara MBBS, PGDM, FWACS, Melesse Gebeyehu MD, Mesele Bogale MD, Khaled Twier MMed, FCS, Marco Faniriko MD, FCS, Getachew Beza Melesse MD, Mark G. Shrime MD, PhD, MPH
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:OTO Open
Online Access:https://doi.org/10.1177/2473974X20938313
_version_ 1797425180383903744
author Johannes J. Fagan MBChB, MMed, FCS
Julie Wetter MBChB, MMed, FCRadOnc
Jeffrey Otiti MBCHB, MMed
Joyce Aswani MBChB, MMed
Anna Konney MD, FWACS, FGCPS
Evelyne Diom
Kenneth Baidoo MD, FWACS, FGCS
Paul Onakoya MBBS
Rajab Mugabo MMed
Patrick Noah MBBS, FCS
Victor Mashamba MD, MMed
Innocent Kundiona MBChB, MMed
Chege Macharia MBChB, FCS
Mohammed Garba Mainasara MBBS, PGDM, FWACS
Melesse Gebeyehu MD
Mesele Bogale MD
Khaled Twier MMed, FCS
Marco Faniriko MD, FCS
Getachew Beza Melesse MD
Mark G. Shrime MD, PhD, MPH
author_facet Johannes J. Fagan MBChB, MMed, FCS
Julie Wetter MBChB, MMed, FCRadOnc
Jeffrey Otiti MBCHB, MMed
Joyce Aswani MBChB, MMed
Anna Konney MD, FWACS, FGCPS
Evelyne Diom
Kenneth Baidoo MD, FWACS, FGCS
Paul Onakoya MBBS
Rajab Mugabo MMed
Patrick Noah MBBS, FCS
Victor Mashamba MD, MMed
Innocent Kundiona MBChB, MMed
Chege Macharia MBChB, FCS
Mohammed Garba Mainasara MBBS, PGDM, FWACS
Melesse Gebeyehu MD
Mesele Bogale MD
Khaled Twier MMed, FCS
Marco Faniriko MD, FCS
Getachew Beza Melesse MD
Mark G. Shrime MD, PhD, MPH
author_sort Johannes J. Fagan MBChB, MMed, FCS
collection DOAJ
description By 2030, 70% of cancers will occur in developing countries. Head and neck cancers are primarily a developing world disease. While anatomical location and the extent of cancers are central to defining prognosis and staging, the American Joint Committee on Cancer (AJCC)/International Union Against Cancer (UICC) have incorporated nonanatomic factors that correlate with prognosis into staging (eg, p16 status of oropharyngeal cancers). However, 16 of 17 head and neck surgeons from 13 African countries cannot routinely test for p16 status and hence can no longer apply AJCC/UICC staging to oropharyngeal cancer. While the AJCC/UICC should continue to refine staging that best reflects treatment outcomes and prognosis by incorporating new nonanatomical factors, they should also retain and refine anatomically based staging to serve the needs of clinicians and their patients in resource-constrained settings. Not to do so would diminish their global relevance and in so doing also disadvantage most of the world’s cancer patients.
first_indexed 2024-03-09T08:12:20Z
format Article
id doaj.art-2a8ece41acd54e2c9d3a7002235b6b8b
institution Directory Open Access Journal
issn 2473-974X
language English
last_indexed 2024-03-09T08:12:20Z
publishDate 2020-07-01
publisher Wiley
record_format Article
series OTO Open
spelling doaj.art-2a8ece41acd54e2c9d3a7002235b6b8b2023-12-02T23:07:05ZengWileyOTO Open2473-974X2020-07-01410.1177/2473974X20938313Is AJCC/UICC Staging Still Appropriate for Head and Neck Cancers in Developing Countries?Johannes J. Fagan MBChB, MMed, FCS0Julie Wetter MBChB, MMed, FCRadOnc1Jeffrey Otiti MBCHB, MMed2Joyce Aswani MBChB, MMed3Anna Konney MD, FWACS, FGCPS4Evelyne Diom5Kenneth Baidoo MD, FWACS, FGCS6Paul Onakoya MBBS7Rajab Mugabo MMed8Patrick Noah MBBS, FCS9Victor Mashamba MD, MMed10Innocent Kundiona MBChB, MMed11Chege Macharia MBChB, FCS12Mohammed Garba Mainasara MBBS, PGDM, FWACS13Melesse Gebeyehu MD14Mesele Bogale MD15Khaled Twier MMed, FCS16Marco Faniriko MD, FCS17Getachew Beza Melesse MD18Mark G. Shrime MD, PhD, MPH19Division of Otolaryngology, University of Cape Town, South AfricaDepartment Radiation Oncology, Groote Schuur Hospital, University of Cape Town, Cape Town, South AfricaUganda Cancer Institute, Kampala, UgandaDepartment of Surgery, College of Health Sciences, University of Nairobi, Nairobi, KenyaENT Department, Komfo Anokye Teaching Hospital, Kumasi, GhanaDivision of Otolaryngology, Hôpital de la Paix, Universite Assane Seck, Ziguinchor, SenegalKorle Bu Teaching Hospital, Accra, GhanaUniversity of Ibadan/University College Hospital, Ibadan, NigeriaThe Aga Khan Hospital, Dar es Salaam, TanzaniaCollege of Medicine, Blantyre, MalawiMuhimbili National Hospital, Dar Es Salaam, TanzaniaHarare, ZimbabweAIC Kijabe Hospital, KenyaNational Ear Care Centre Kaduna Nigeria, Kaduna, NigeriaBahir dar University, EthiopiaAdama General Hospital, Adam, EthiopiaOshakati, Namibia and LibyaLutheran Hospital Salfa Sambava, MadagascarHawassa University Referral Hospital, Hawassa, EthiopiaProgram in Global Surgery and Social Change, Harvard Medical School and Center for Global Surgery Evaluation, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USABy 2030, 70% of cancers will occur in developing countries. Head and neck cancers are primarily a developing world disease. While anatomical location and the extent of cancers are central to defining prognosis and staging, the American Joint Committee on Cancer (AJCC)/International Union Against Cancer (UICC) have incorporated nonanatomic factors that correlate with prognosis into staging (eg, p16 status of oropharyngeal cancers). However, 16 of 17 head and neck surgeons from 13 African countries cannot routinely test for p16 status and hence can no longer apply AJCC/UICC staging to oropharyngeal cancer. While the AJCC/UICC should continue to refine staging that best reflects treatment outcomes and prognosis by incorporating new nonanatomical factors, they should also retain and refine anatomically based staging to serve the needs of clinicians and their patients in resource-constrained settings. Not to do so would diminish their global relevance and in so doing also disadvantage most of the world’s cancer patients.https://doi.org/10.1177/2473974X20938313
spellingShingle Johannes J. Fagan MBChB, MMed, FCS
Julie Wetter MBChB, MMed, FCRadOnc
Jeffrey Otiti MBCHB, MMed
Joyce Aswani MBChB, MMed
Anna Konney MD, FWACS, FGCPS
Evelyne Diom
Kenneth Baidoo MD, FWACS, FGCS
Paul Onakoya MBBS
Rajab Mugabo MMed
Patrick Noah MBBS, FCS
Victor Mashamba MD, MMed
Innocent Kundiona MBChB, MMed
Chege Macharia MBChB, FCS
Mohammed Garba Mainasara MBBS, PGDM, FWACS
Melesse Gebeyehu MD
Mesele Bogale MD
Khaled Twier MMed, FCS
Marco Faniriko MD, FCS
Getachew Beza Melesse MD
Mark G. Shrime MD, PhD, MPH
Is AJCC/UICC Staging Still Appropriate for Head and Neck Cancers in Developing Countries?
OTO Open
title Is AJCC/UICC Staging Still Appropriate for Head and Neck Cancers in Developing Countries?
title_full Is AJCC/UICC Staging Still Appropriate for Head and Neck Cancers in Developing Countries?
title_fullStr Is AJCC/UICC Staging Still Appropriate for Head and Neck Cancers in Developing Countries?
title_full_unstemmed Is AJCC/UICC Staging Still Appropriate for Head and Neck Cancers in Developing Countries?
title_short Is AJCC/UICC Staging Still Appropriate for Head and Neck Cancers in Developing Countries?
title_sort is ajcc uicc staging still appropriate for head and neck cancers in developing countries
url https://doi.org/10.1177/2473974X20938313
work_keys_str_mv AT johannesjfaganmbchbmmedfcs isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT juliewettermbchbmmedfcradonc isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT jeffreyotitimbchbmmed isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT joyceaswanimbchbmmed isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT annakonneymdfwacsfgcps isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT evelynediom isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT kennethbaidoomdfwacsfgcs isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT paulonakoyambbs isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT rajabmugabommed isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT patricknoahmbbsfcs isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT victormashambamdmmed isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT innocentkundionambchbmmed isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT chegemachariambchbfcs isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT mohammedgarbamainasarambbspgdmfwacs isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT melessegebeyehumd isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT meselebogalemd isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT khaledtwiermmedfcs isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT marcofanirikomdfcs isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT getachewbezamelessemd isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries
AT markgshrimemdphdmph isajccuiccstagingstillappropriateforheadandneckcancersindevelopingcountries